Pharmacy News Articles

▼ Show details

MDLinx Pharmacy helps physicians and healthcare professionals stay up to date with the latest pharmacy news articles and research, as well as pharmacy jobs, conferences, and resources.

Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting beta2-adrenergic agonist, in asthma; a Phase II, randomized study Full Text BMC Pulmonary Medicine, November 21, 2014    Clinical Article

2 Effects of antiplatelet agents on functional outcome and cognitive status in patients with acute ischemic stroke Full Text International Journal of Gerontology, November 21, 2014    Clinical Article

3 Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: A phase 1/2 trial The Lancet Oncology, November 21, 2014    Clinical Article

4 Targeting glutamatergic synapses in Parkinson's disease Current Opinion in Pharmacology , November 21, 2014    Review Article

5 Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: A double-blind, randomized, clinical trial Clinical Infectious Diseases, November 21, 2014    Clinical Article

6 Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy Clinical & Experimental Allergy, November 21, 2014    Clinical Article

7 Ripasudil: first global approval Drugs, November 21, 2014    Clinical Article

8 Pomelo enhances cyclosporine bioavailability in healthy male Thai volunteers The Journal of Clinical Pharmacology, November 21, 2014    Clinical Article

9 Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease European Neurology, November 21, 2014    Clinical Article

10 Acetaminophen prescription combination drug products with more than 325 mg: FDA statement – recommendation to discontinue prescribing and dispensing Full Text Purdue Pharma, November 21, 2014

11 Hypnotics in insomnia: the experience of zolpidem Clinical Therapeutics, November 21, 2014    Clinical Article

12 Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): A phase 3, multicentre, randomised trial The Lancet Oncology, November 21, 2014    Clinical Article

13 Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: Updated results from the phase III HannaH study Annals of Oncology, November 21, 2014    Clinical Article

14 A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials Annals of Oncology, November 21, 2014    Clinical Article

15 Development of quality measures for the care of patients with gastroesophageal reflux disease Clinical Gastroenterology and Hepatology , November 21, 2014    Clinical Article

16 Pharmacokinetics of atazanavir/ritonavir among HIV-infected Thai children concomitantly taking tenofovir disoproxil fumarate The Pediatric Infectious Disease Journal, November 21, 2014    Clinical Article

17 Chronic thalidomide and chemoembolization for hepatocellular carcinoma Full Text The Oncologist, November 21, 2014    Clinical Article

18 Sanofi and Regeneron announce that dupilumab has received FDA breakthrough therapy designation in atopic dermatitis Full Text Sanofi, November 21, 2014

19 Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation Sleep Medicine Reviews , November 21, 2014    Clinical Article

20 Drug sales data analysis for outbreak detection of infectious diseases: A systematic literature review Full Text BMC Infectious Diseases, November 21, 2014    Review Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Pharmacy